Further study revealed that cell proliferation and tumor progression were increased in cell overexpression CD36 while being reduced by CD36 inhibition (Figs. 4, 5 and 6), indicating that CD36 is a central regulator for NSCLC progression. This evidence concerns the gene CD36 and neoplasm.